FDA Clearance Tracker · K233602
P200TE (A10700)
Last checked: Nov 19, 2026Latest source record: May 9, 2024 (this decision)Source: openFDAMethods & limitations
Decided
May 9, 2024
Substantially Equivalent
Time to decision
182 days
Received Nov 9, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K233602
- Device name
- P200TE (A10700)
- Applicant
- Optos Plc.
- Applicant location
- Dunfermline, GB
- Received
- Nov 9, 2023
- Decided
- May 9, 2024
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Tomography, Optical Coherence (OBO)
- Device class
- Class II
- Regulation
- 21 CFR 886.1570
- Specialty
- Ophthalmology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code OBO. The earliest in FDA's data is K062552, decided Oct 6, 2006.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K233602
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Optos Plc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- P200TE (A10700)510(k)
K231673 · Decided Aug 18, 2023 · 71 days after receipt
Device type: Tomography, Optical Coherence (OBO) · Ophthalmology
- P200TxE510(k)
K190732 · Decided Jul 31, 2019 · 132 days after receipt
Device type: Tomography, Optical Coherence (OBO) · Ophthalmology
- P200TE510(k)
K173707 · Decided Feb 28, 2018 · 86 days after receipt
Device type: Tomography, Optical Coherence (OBO) · Ophthalmology
2 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.